ALETA-001 clinical trials

A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

This study is testing a new medicine, ALETA-001, for people with certain types of B-cell lymphoma. It's for those who have already had a specific CAR T-cell treatment. The study will look at how safe and effective ALETA-001 is.